Galen Health

Our solution uses a two-step process combining AI and blood tests to catch pancreatic cancer early when it's still treatable. In stage 1, our AI scans routine electronic health records to spot patients who are at high risk. In stage 2, these high-risk patients get liquid biopsies twice a year to monitor for early signs of cancer. With the AI screening step we are able to cast a wider net catching unsuspecting asymptomatic patients without any need for patient initiated action.